Phosphorylation of STAT3 in head and neck cancer requires p38 MAPKinase, whereas phosphorylation of STAT1 occurs via a different signaling pathway

Anticancer Research

Volumn 31, Issue 11, 2011, Pages 3819-3825

  Riebe, Christine ^a   Pries, Ralph ^a   Schroeder, Kim Ninja ^a   Wollenberg, Barbara ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Head and neck cancer; p38 MAPK; Phosphorylation; STAT1; STAT3

Indexed keywords

INTERLEUKIN 6; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; SMALL INTERFERING RNA; STAT1 PROTEIN; STAT3 PROTEIN;

ARTICLE; CANCER GROWTH; DOWN REGULATION; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; DOWN-REGULATION; HEAD AND NECK NEOPLASMS; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; STAT3 TRANSCRIPTION FACTOR; TUMOR CELLS, CULTURED; TYROSINE;

EID: 83055187091     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Luce D, Guenel P, Leclerc A, Brugere J, Point D and Rodriguez J: Alcohol and tobacco consumption in cancer of the mouth, pharynx, and larynx: a study of 316 female patients. Laryngoscope 98: 313-316, 1988. (Pubitemid 18092927)
2. Snow GB: Follow-up in patients treated for head and neck cancer: How frequent, how thorough and for how long? Eur J Cancer 28: 315-316, 1992.
3. Berrino F, Esteve J and Coleman MP: Basic issues in estimating and comparing the survival of cancer patients. IARC Sci Publ 1-14, 1995.
4. St John MA, Abemayor E and Wong DT: Recent new approaches to the treatment of head and neck cancer. Anticancer Drugs 17: 365-375, 2006. (Pubitemid 44309978)
5. Kraunz KS, McClean MD, Nelson HH, Peters E, Calderon H and Kelsey KT: Duration but not intensity of alcohol and tobacco exposure predicts p16 INK4A homozygous deletion in head and neck squamous cell carcinoma. Cancer Res 66: 4512-4515, 2006.
6. Chin D, Boyle GM, Porceddu S, Theile DR, Parsons PG and Coman WB: Head and neck cancer: past, present and future. Expert Rev Anticancer Ther 6: 1111-1118, 2006. (Pubitemid 44203388)
7. Whiteside TL: Immune suppression in cancer: effects on immune cells, mechanisms and future therapeutic intervention. Semin Cancer Biol 16: 3-15, 2006.
8. + T-regulatory cells: role of tumor-derived TGF-beta. J Immunol 178: 2883-2892, 2007.
9. Pries R, Nitsch S and Wollenberg B: Role of cytokines in head and neck squamous cell carcinoma. Expert Rev Anticancer Ther 6: 1195-1203, 2006.
10. Chin D, Boyle GM, Theile DR, Parsons PG and Coman WB: Molecular introduction to head and neck cancer (HNSCC) carcinogenesis. Br J Plast Surg 57: 595-602, 2004. (Pubitemid 40348040)
11. Douglas WG, Tracy E, Tan D, Yu J, Hicks W L Jr, Rigual NR, Loree TR, Wang Y and Baumann H: Development of head and neck squamous cell carcinoma is associated with altered cytokine responsiveness. Mol Cancer Res 2: 585-593, 2004. (Pubitemid 39403387)
12. Levy D E and Darnell J E Jr.: Stats: transcriptional control and biological impact. Nat Rev Mol Cell Biol 3: 651-662, 2002. (Pubitemid 34987786)
13. Schindler C, Levy D E and Decker T: JAK-STAT signaling: from interferons to cytokines. J Biol Chem 282: 20059-20063, 2007. (Pubitemid 47099977)
14. Song J I and Grandis J R: STAT signaling in head and neck cancer. Oncogene 19: 2489-2495, 2000. (Pubitemid 30339204)
15. Quesnelle KM, Boehm AL and Grandis JR: STAT-mediated EGFR signaling in cancer. J Cell Biochem 102: 311-319, 2007. (Pubitemid 47519405)
16. Decker T and Kovarik P: Serine phosphorylation of STATs. Oncogene 19: 2628-2637, 2000. (Pubitemid 30339219)
17. Yu H, Pardoll D and Jove R: STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer 9: 798-809, 2009.
18. Lee TL, Yeh J, Friedman J, Yan B, Yang X, Yeh NT, Van Waes C and Chen ZA: Signal network involving coactivated NF-kappaB and STAT3 and altered p53 modulates BAX/BCL-XL expression and promotes cell survival of head and neck squamous cell carcinomas. Int J Cancer 122: 1987-1998, 2008. (Pubitemid 351441187)
19. Lui VW, Boehm AL, Koppikar P, Leeman RJ, Johnson D, Ogagan M, Childs E, Freilino M and Grandis JR: Antiproliferative mechanisms of a transcription factor decoy targeting signal transducer and activator of transcription (STAT) 3: the role of STAT1. Mol Pharmacol 71: 1435-1443, 2007. (Pubitemid 46658696)
20. Shen Y, Devgan G, Darnell J E Jr. and Bromberg JF: Constitutively activated Stat3 protects fibroblasts from serum withdrawal and UV-induced apoptosis and antagonizes the proapoptotic effects of activated Stat1. Proc Natl Acad Sci USA 98: 1543-1548, 2001. (Pubitemid 32165535)
21. Shim SH, Sung MW, Park SW and Heo DS: Absence of STAT1 disturbs the anticancer effect induced by STAT3 inhibition in head and neck carcinoma cell lines. Int J Mol Med 23: 805-810, 2009.
22. Watanabe G, Kaganoi J, Imamura M, Shimada Y, Itami A, Uchida S, Sato F and Kitagawa M: Progression of esophageal carcinoma by loss of EGF-STAT1 pathway. Cancer J 7: 132-139, 2001.
23. Masuda M, Suzui M, Yasumatu R, Nakashima T, Kuratomi Y, Azuma K, Tomita K, Komiyama S and Weinstein IB: Constitutive activation of signal transducers and activators of transcription 3 correlates with cyclin D1 overexpression and may provide a novel prognostic marker in head and neck squamous cell carcinoma. Cancer Res 62: 3351-3355, 2002.
24. Goh KC, Haque SJ and Williams BR: p38 MAP kinase is required for STAT1 serine phosphorylation and transcriptional activation induced by interferons. Embo J 18: 5601-5608, 1999. (Pubitemid 29486379)
25. Yonezawa K, Yoshino KI, Tokunaga C and Hara K: Kinase activities associated with mTOR. Curr Top Microbiol Immunol 279: 271-282, 2004. (Pubitemid 37047268)
26. Aziz MH, Manoharan HT, Sand JM and Verma AK: Protein kinase C epsilon interacts with Stat3 and regulates its activation that is essential for the development of skin cancer. Mol Carcinog 46: 646-653, 2007. (Pubitemid 47255182)
27. Gartsbein M, Alt A, Hashimoto K, Nakajima K, Kuroki T and Tennenbaum T: The role of protein kinase C delta activation and STAT3 Ser727 phosphorylation in insulin-induced keratinocyte proliferation. J Cell Sci 119: 470-481, 2006.
28. Kovarik P, Stoiber D, Eyers PA, Menghini R, Neininger A, Gaestel M, Cohen P and Decker T: Stress-induced phosphorylation of STAT1 at Ser727 requires p38 mitogen-activated protein kinase whereas IFN-gamma uses a different signaling pathway. Proc Natl Acad Sci USA 96: 13956-13961, 1999.
29. Ramsauer K, Sadzak I, Porras A, Pilz A, Nebreda AR, Decker T and Kovarik P: p38 MAPK enhances STAT1-dependent transcription independently of Ser-727 phosphorylation. Proc Natl Acad Sci USA 99: 12859-12864, 2002.
30. Kovarik P, Stoiber D, Novy M and Decker T: Stat1 combines signals derived from IFN-gamma and LPS receptors during macrophage activation. EMBO J 17: 3660-3668, 1998. (Pubitemid 28327384)
31. Gotoh A, Takahira H, Mantel C, Litz-Jackson S, Boswell HS and Broxmeyer HE: Steel factor induces serine phosphorylation of Stat3 in human growth factor-dependent myeloid cell lines. Blood 88: 138-145, 1996. (Pubitemid 26230681)
32. Timofeeva OA, Plisov S, Evseev AA, Peng S, Jose-Kampfner M, Lovvorn HN, Dome JS and Perantoni AO: Serine-phosphorylated STAT1 is a prosurvival factor in Wilms' tumor pathogenesis. Oncogene 25: 7555-7564, 2006. (Pubitemid 44924469)
33. Lee CK, Smith E, Gimeno R, Gertner R and Levy DE: STAT1 affects lymphocyte survival and proliferation partially independent of its role downstream of IFN-gamma. J Immunol 164: 1286-1292, 2000. (Pubitemid 30067241)
34. Kaplan DH, Shankaran V, Dighe AS, Stocken E, Aguet M, Old LJ and Schreiber RD: Demonstration of an interferon gammadependent tumor surveillance system in immunocompetent mice. Proc Natl Acad Sci USA 95: 7556-7561, 1998. (Pubitemid 28293291)
35. Leeman RJ, Lui VW and Grandis JR: STAT3 as a therapeutic target in head and neck cancer. Expert Opin Biol Ther 6: 231-241, 2006. (Pubitemid 43344743)
36. Squarize CH, Castilho RM, Sriuranpong V, Pinto DS Jr and Gutkind JS: Molecular cross-talk between the NFkappaB and STAT3 signaling pathways in head and neck squamous cell carcinoma. Neoplasia 8: 733-746, 2006. (Pubitemid 44465525)